fraxiparine iuinj 0.3ml
sanofi aventis - l m w h - 3075 i.u.(nadroparin) - 0.3ml
fraxiparine 3800 iu axa/ 0.4 ml
glaxo smith kline (israel) ltd - nadroparin calcium 3800 iu / 0.4 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during heamodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
fraxiparine 2850 iu axa/0.3 ml
glaxo smith kline (israel) ltd - nadroparin calcium 2850 iu / 0.3 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
fraxiparine 5700 iu axa/0.6 ml
glaxo smith kline (israel) ltd - nadroparin calcium 5700 iu / 0.6 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
fraxiparine 7600 iu axa/0.8 ml
glaxo smith kline (israel) ltd - nadroparin calcium 7600 iu / 0.8 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
fraxiparine 25000 icu/ml prefilled syringe
glaxo smithkline-egypt - injection - 25000 i.c.u
fraxiparine 25000 icu/ml prefilled syringe
glaxo smithkline-egypt - injection - 25000 i.c.u
fraxiparine 25000 icu/ml prefilled syringe
glaxo smithkline-egypt - injection - 25000 i.c.u
fraxiparine injectable solution 1900 iu/0.2ml
wael pharmacy - calcium nadoparin(lmwh) - injectable solution - 1900
fraxiparine injectable solution 2850 iu/0.3ml
wael pharmacy - calcium nadoparin(lmwh), low molecular weight heparin (calc.nadoparin) - injectable solution - 2850